Tiziana Life Sciences annual return on equity
2017
2019
2020
2021
2022
2023
2024
2025
Tiziana Life Sciences Return on Equity (ROE) Growth & History (TLSA)
Tiziana Life Sciences's return on equity was −924.32% for fiscal 2025.
View full Tiziana Life Sciences company overviewTiziana Life Sciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −924.32% | −673.84 pp |
| 2024 | 2024-12-31 | −250.49% | −109.56 pp |
| 2023 | 2023-12-31 | −140.92% | −90.32 pp |
| 2022 | 2022-12-31 | −50.61% | −5.43 pp |
| 2021 | 2021-12-31 | −45.18% | −5.59 pp |
| 2020 | 2020-12-31 | −39.59% | −13.01 pp |
| 2019 | 2019-12-31 | −26.58% | — |
| 2017 | 2017-12-31 | −949.50% | — |
Tiziana Life Sciences return on equity trends
Over the last five fiscal years, Tiziana Life Sciences's return on equity decreased from −39.59% to −924.32%, a change of −884.74 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tiziana Life Sciences source filings ↗